| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,182 | 27,870 | 30,248 | 29,650 | | Cost of Revenue | 18,758 | 16,204 | 21,644 | 21,629 | | | Gross Profit | 12,424 | 11,666 | 8,604 | 8,021 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,914 | 13,978 | 11,566 | 27,291 | | Non Recurring |
-
| (177) | 177 | 611 | | Others | 4,517 | 4,123 | 3,617 | 2,725 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,007) | (6,259) | (6,756) | (22,606) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (107) | (146) | (40) | 267 | | Earnings Before Interest And Taxes | (18,405) | (6,369) | (6,780) | (22,407) | | Interest Expense | (92) | 60 | 33 |
-
| | Income Before Tax | (18,313) | (6,429) | (6,812) | (22,407) | | Income Tax Expense | 68 | 73 | 68 | 90 | | Minority Interest |
-
|
-
|
-
| 119 | | | | Net Income From Continuing Ops | (17,820) | (6,502) | (6,880) | (22,378) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,950) | (6,502) | (6,880) | (22,378) | | Preferred Stock And Other Adjustments | (511) | 125 | 386 |
-
| | | Net Income Applicable To Common Shares | ($18,461) | ($6,377) | ($6,494) | ($22,378) |
|
0.06% Nasdaq 
1.52 (9.13%) 
Income Statement
